VIZZA, Carmine Dario
 Distribuzione geografica
Continente #
NA - Nord America 6.581
EU - Europa 3.006
AS - Asia 817
SA - Sud America 67
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 10.535
Nazione #
US - Stati Uniti d'America 6.508
IT - Italia 1.483
SE - Svezia 419
IN - India 384
UA - Ucraina 341
CN - Cina 240
FI - Finlandia 201
DE - Germania 116
SG - Singapore 116
GB - Regno Unito 109
FR - Francia 73
BG - Bulgaria 59
CA - Canada 51
TG - Togo 49
AR - Argentina 48
NL - Olanda 46
IE - Irlanda 38
RO - Romania 30
IR - Iran 21
MX - Messico 19
BE - Belgio 17
CH - Svizzera 16
LT - Lituania 15
HK - Hong Kong 10
RU - Federazione Russa 9
MY - Malesia 7
TW - Taiwan 7
CL - Cile 6
GR - Grecia 6
TR - Turchia 6
BR - Brasile 5
CO - Colombia 5
VN - Vietnam 5
ES - Italia 4
EU - Europa 4
PL - Polonia 4
TH - Thailandia 4
AU - Australia 3
HR - Croazia 3
PK - Pakistan 3
AT - Austria 2
AZ - Azerbaigian 2
BD - Bangladesh 2
EG - Egitto 2
IL - Israele 2
JP - Giappone 2
LU - Lussemburgo 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
ZA - Sudafrica 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
ID - Indonesia 1
IQ - Iraq 1
KR - Corea 1
KZ - Kazakistan 1
MT - Malta 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
SC - Seychelles 1
SI - Slovenia 1
Totale 10.535
Città #
Fairfield 931
Chandler 541
Woodbridge 476
Ashburn 434
Rome 394
Seattle 351
Cambridge 331
Houston 296
Wilmington 296
Ann Arbor 291
Princeton 259
Dearborn 252
Plano 164
Beijing 145
Jacksonville 119
San Paolo di Civitate 115
San Diego 113
Boston 107
Lawrence 101
Milan 97
Millbury 89
Andover 60
Sofia 58
Des Moines 57
Lomé 49
Federal 45
Toronto 42
Fremont 38
Bremen 37
Dublin 37
New York 37
Helsinki 36
Singapore 36
Boardman 30
Norwalk 27
Southend 24
Groningen 20
San Mateo 19
Brussels 17
Bühl 17
Falls Church 16
Bergamo 15
Hefei 15
Leawood 15
London 15
Klaipėda 13
Kunming 13
Naples 12
Bari 11
Lappeenranta 11
Nanjing 10
Paris 10
Florence 9
Grafing 9
Rende 9
Verona 9
Zanjan 9
Puebla City 8
Amsterdam 7
Bologna 7
Lowestoft 7
Torino 7
Cardito 6
Catania 6
Central 6
Jinan 6
Marino 6
Mexico City 6
Ottawa 6
Padova 6
Pune 6
Temuco 6
Treviso 6
Turin 6
Atlanta 5
Bogotá 5
Chengdu 5
Coyoacán 5
Custonaci 5
Genoa 5
Kuala Lumpur 5
Nanchang 5
Nocera Superiore 5
Phoenix 5
Riva del Garda 5
Taranto 5
Adelfia 4
Amandola 4
Balzola 4
Brescia 4
Buffalo 4
Carrara 4
Formia 4
Ho Chi Minh City 4
Hong Kong 4
Indiana 4
Loutsa 4
Napoli 4
Redwood City 4
Shanghai 4
Totale 7.013
Nome #
Significato del sottoslivellamento del tratto ST nelle derivazioni precordiali in corso di infarto miocardico acuto della parete inferiore 673
Right ventricular dyssynchrony and exercise capacity in idiopathic pulmonary arterial hypertension 116
Right ventricular concentric hypertrophy and clinical worsening in idiopathic pulmonary arterial hypertension 101
Right heart and pulmonary vessels structure and function 100
Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy A Randomized, Controlled Clinical Trial Using Magnetic Resonance Imaging With Myocardial Tagging 95
Echocardiography combined with cardiopulmonary exercise testing for the prediction of outcome in idiopathic pulmonary arterial hypertension 95
Letter to the editor about the paper “right ventricular dyssynchrony predicts clinical outcomes in patients with pulmonary hypertension” by murata et al 95
Prognostic relevance of right heart reverse remodeling in idiopathic pulmonary arterial hypertension 92
Transesophageal dipyridamole echocardiography for diagnosis of coronary artery disease. 91
Ruolo prognostico a lungo termine dell'ipertensione polmonare nei pazienti con acuta decompensated heart failure : valutazione all'ingresso in ospedale e in pre-dimissione. Roberto Badagliacca, Stefano Ghio, Michele Correale, Pasquale Petrone, Giordana Ferraioli, Beatrice Pezzuto, Roberto Poscia, Laura Scelsi, Giovanna Manzi, Silvia Papa, Daniele Berardi, Ferraretti Armando, Francesco Fedele, Carmine Dario Vizza 88
The added value of cardiopulmonary exercise testing in the follow-up of pulmonary arterial hypertension 87
Human Herpesvirus 8 and Pulmonary Hypertension. 85
Right ventricular remodeling in idiopathic pulmonary arterial hypertension. adaptive versus maladaptive morphology 85
Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor β in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension. 85
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension 84
Ambrisentan for the treatment of adults with pulmonary arterial hypertension. a review 80
Cardiovascular effects of chronic sildenafil in men with type 2 diabetes 79
Acute hemodynamic effects of single-dose sildenafil when added to established bosentan therapy in patients with pulmonary arterial hypertension: Results of the COMPASS-1 study 79
Pulmonary hemodynamics contribute to indicate priority for lung transplantation in patients with cystic fibrosis 79
Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study. 78
Psychological counselling interventions to improve perceived quality of life and counter anxiety and depression in pulmonary-arterial-hypertension patients. a clinical trial 77
Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease 77
Circulating biomarkers in pulmonary arterial hypertension. update and future direction 77
Long-term safety and efficacy of imatinib in pulmonary arterial hypertension 77
Analysis of endothelin-1 and endothelin-1 receptor A gene polymorphisms in patients with pulmonary arterial hypertension. 77
Tissue-type plasminogen activator therapy versus primary coronary angioplasty: Impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction 76
Right intraventricular dyssynchrony in idiopathic, heritable, and anorexigen-induced pulmonary arterial hypertension. Cllinical impact and reversibility 75
Mortality in pulmonary arterial hypertension. prediction by the 2015 european pulmonary hypertension guidelines risk stratification model 74
Right ventricular dyssynchrony in idiopathic pulmonary arterial hypertension: determinants and impact on pump function 72
Abnormal behavior of the forearm vasculature during ergometric test in hypertrophic cardiomyopathy 71
Pulmonary Arterial Dilatation in Pulmonary Hypertension: Prevalence and Prognostic Relevance 71
Response to letters regarding article, "anticoagulation and survival in pulmonary arterial hypertension: Results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA)" 71
Locoregional versus general anesthesia in carotid surgery: Is there an impact on peri-operative myocardial ischemia? Results of a prospective monocentric randomized trial. 70
Identification of coronary artery by-pass grafts: reliability of MRI in clinical practice. 69
Pathophysiological adaptations to walking and cycling in primary pulmonary hypertension 69
Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension 69
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease. a randomized controlled multicenter clinical trial 69
An official european respiratory society statement. pulmonary haemodynamics during exercise 68
Improved results with lung transplantation for cystic fibrosis 67
Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study 67
Clinical impact of echocardiography in prognostic stratification after acute myocardial infarction 67
Right ventricular strain curve morphology and outcome in idiopathic pulmonary arterial hypertension 67
Sex-specific effects of daily tadalafil on diabetic heart kinetics in RECOGITO, a randomized, double-blind, placebo-controlled trial 67
Echo stress in functional evaluation of dilated cardiomyopathy. 66
Changes in Right Ventricular Function Measured by Cardiac Magnetic Resonance Imaging in Patients Receiving Pulmonary Arterial Hypertension-Targeted Therapy The EURO-MR Study 66
Plasma adrenomedullin and endothelin-1 concentration during low-dose dobutamine infusion: Relationship between pulmonary uptake and pulmonary vascular pressure/flow characteristics 66
Tissue viability by contrast echocardiography 66
Usefulness of adding echocardiography of the right heart to risk-assessment scores in prostanoid-treated pulmonary arterial hypertension 66
Timing and priorities for cystic fibrosis patients candidates to lung transplantation 65
Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy. the impact of late referral. 65
Comparative Effects of Irbesartan Versus Amlodipine on Left Ventricular Mass Index in Hypertensive Patients with Left Ventricular Hypertrophy 65
Usefulness of 2D echo Doppler in the preoperative assessment of cystic fibrosis patients who are candidates for lung transplantation 65
Relationship between baseline ET-1 plasma levels and outcome in patients with idiopathic pulmonary hypertension treated with bosentan 65
Usefulness of the dipyridamole-Doppler test for diagnosis of coronary artery disease 64
Prognostic significance of the echocardiographic estimate of pulmonary hypertension and of right ventricular dysfunction in acute decompensated heart failure. a pilot study in HFrEF patients 64
Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: Retrospective results from six European countries 64
Myocardial and microvascular inflammation/infection in patients with HIV-associated pulmonary artery hypertension 64
Efficacy of 1, 5, and 20mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension. a randomized, double-blind study with open-label extension 63
Occult lung cancer in patients with bullous emphysema 62
Myocardial and micro-vascular inflammation/infection in HIV/HCV associated pulmonary artery hypertension 62
Cardiovascular effects of chronic sildenafil treatment in men with type 2 diabetes 62
Unusual presentation for a patent ductus arteriosus 60
Preoperative evaluation of patients undergoing lung resection surgery. defining the role of the anesthesiologist on a multidisciplinary team 60
Effetti Cardiovascolari della Somministrazione in Cronico di Sildenafil in Soggetti con ?Diabete Mellito di tipo 2 59
Supravalvular aortic stenosis and pulmonary artery stenosis: echocardiographic and clinical aspects. 59
Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): Safety, tolerability, clinical, and haemodynamic effect 59
Validità dell'ecocardiografia nella valutazione della terapia cardiovascolare 59
Outcome of Patients with Cystic Fibrosis Awaiting Lung Transplantation 59
Assessment of right ventricular inotropic reserve during dobutamine infusion in patients with secondary pulmonary hypertension. 58
Pulmonary arterial hypertension: current therapies. 58
Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial 58
Heart failure pharmacological management. gaps and current perspectives 57
Safety and efficacy evaluation of ambrisentan in pulmonary hypertension 57
Endogenous opioid system modulation in anginal pain: demonstration of its central activity. 57
PROSTANOID THERAPY FOR PULMONARY ARTERIAL HYPERTENSION. 56
Pulmonary hypertension in patients with chronic fibrosing idiopathic interstitial pneumonias 55
Endocrine and metabolic alterations in patients with pulmonary arterial hypertension 55
Dal Tromboembolismo Venoso all’Ipertensione Polmonare cronica tromboembolica 54
Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. 54
RESPITE. switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors 54
Right ventricular assessment matters for precision medicine.. reply to "Identifying parameters associated with response to switching from a PDE5i to riociguat in RESPITE" 54
Cardiac and vascular remodeling after 6 months of therapy with sacubitril/valsartan. mechanistic insights from advanced echocardiographic analysis 54
'Real-life' information on pulmonary arterial hypertension: The iPHnet Project 53
Effects of glucose-insulin-potassium infusion on myocardial perfusion and left ventricular remodeling in patients treated with primary angioplasty for ST-elevation acute myocardial infarction. 53
Prognostic relevance of pulmonary arterial compliance after therapy initiation or escalation in patients with pulmonary arterial hypertension 53
Hemodynamics during inhaled nitric oxide in lung transplant candidates 53
Inhaled areosolized prostacyclin and pulmonary hypertension during anesthesia for lung transplantation 52
Isolated lung transplantation for end-stage lung disease 52
Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension. 52
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. 51
Reconstruction of the pulmonary artery by a conduit of autologous pericardium. 51
[Role of the endogenous opioid system in the modulation of anginal pain]. 50
Acute pulmonary vascular response to inhaled nitric oxide,dobutamine and their association in patients with secondary pulmonary hypertension. 50
The importance of right ventricular function in patients with pulmonary arterial hypertension 50
Role of endogenous opioids on nociceptive threshold in patients with exercise-induced myocardial ischemia. 49
Effetti Cardiovascolari della Somministrazione in Cronico di Sildenafil in Soggetti affetti da Diabete Mellito di tipo 2 48
Mid-term efficacy of beraprost, an oral prostacyclin analog, in the treatment of distal CTEPH: A case control study 48
Badagliacca R, Papa S, Valli G, Pezzuto B, Poscia R, Murace AC, Marinelli L, Manzi G, Berardi D, Sciomer S, Palange P, Fedele F, Vizza CD. “Incremental benefit of cardiopulmonary exercise testing for the prediction of outcome in stable prevalent idiopathic pulmonary arterial Hypertension patients”. Comunicazione Abstract del 77° Congresso Nazionale della Società Italiana di Cardiologia (2016) 48
The growing role of echocardiography in pulmonary arterial hypertension risk stratification. the missing piece 48
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry 48
Totale 7.276
Categoria #
all - tutte 32.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019560 0 0 0 0 0 0 0 0 0 0 330 230
2019/20202.048 293 51 19 102 178 373 287 238 197 150 108 52
2020/20211.195 90 101 43 93 54 94 29 95 203 272 93 28
2021/20222.332 49 130 159 82 245 50 54 186 223 285 411 458
2022/20232.480 461 408 144 261 259 273 25 146 260 45 140 58
2023/20241.232 79 199 90 105 152 160 93 127 27 193 7 0
Totale 11.099